### Summary This order revokes the 2021 directive on competition, ending the federal "whole-of-government" effort to curb corporate consolidation. It signals a shift away from aggressive antitrust enforcement, likely benefiting Big Tech and healthcare giants while removing consumer-focused protections. ### Analysis This reversal signals a return to a hands-off antitrust model, stripping away guardrails on non-competes and "junk fees." Republicans overlook how consolidation can ultimately harm rural economies and small businesses. Democrats fail to see that the original order’s executive overreach often created administrative bloat that hampered market agility. By removing these mandates, the administration risks entrenching monopolies at the expense of both workers and smaller innovators.